|
| | Publication Year | Title | Author(s) |
| 21 | 2023 | Augmented ICE in Patients With Poor-Risk Refractory and Relapsed Lymphomas. | Loo, Sun; Lim, Andrew Boon Ming ; Lee, Sze Ting ; Grigg, Andrew P |
| 22 | 2023 | ANZTCT Position Statement: COVID-19 Management in Haematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T cell Patients. | Perram, Jacinta; Purtill, Duncan; Bajel, Ashish; Butler, Jason; O'Brien, Tracey; The, Benjamin; Gilroy, Nicole; Ho, Phoebe J; Doocey, Richard; Hills, Thomas; Perera, Travis; Douglas, Genevieve ; Ramachadran, Shanti; Chee, Lynette; Trotman, Judith; Weinkove, Robert; Keogh, Steven; Fraser, Chris; Cochrane, Tara; Watson, Anne-Marie; Diamond, Peter; Latimer, Maya; Irving, Ian; Blyth, Emily; Cheah, Chan; Cole, Theresa; Milliken, Sam; Yang, Hung; Greenwood, Matthew; Bardy, Peter; Kennedy, Glen; Larsen, Stephen; Conyers, Rachel; Hamad, Nada |
| 23 | 7-Oct-2022 | Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma. | Nath, Christa Ellen; Grigg, Andrew P ; Rosser, Sebastian P A; Estell, Jane; Newman, Elizabeth; Tiley, Campbell; Ramanathan, Sundra; Ho, Shir Jing; Larsen, Stephen; Gibson, John; Presgrave, Peter; Shaw, Peter John; Trotman, Judith |
| 24 | 19-Sep-2022 | Restrictive transfusion thresholds: Have we left patient-centered outcomes behind? | Mo, Allison ; Higgins, Alisa M |
| 25 | Sep-2022 | Diffuse large B-cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. | Wight, Joel C ; Hamad, Nada; Campbell, Belinda A; Ku, Matthew; Lee, Kenneth; Rose, Hannah; Armytage, Tasman; Latimer, Maya; Lee, Hui-Peng; Lee, Sze Ting ; Dickinson, Michael; Khor, Richard ; Verner, Emma |
| 26 | 6-Aug-2022 | The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review. | Kiamanesh, Zahra; Ayati, Narjess ; Sadeghi, Ramin; Hawkes, Eliza A ; Lee, Sze Ting ; Scott, Andrew M |
| 27 | 29-Jul-2022 | A critical evaluation of the role of iron overload in fatty liver disease. | Fernandez, Monique; Lokan, Julie ; Leung, Christopher ; Grigg, Andrew P |
| 28 | Jul-2022 | Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre. | Tam, Constantine S; Gregory, Gareth P; Ku, Matthew; Fleming, Shaun; Handunnetti, Sasanka M; Lee, Denise; Walker, Patricia; Perkins, Andrew; Lew, Thomas E; Sirdesai, Shreerang; Chua, Chong Chyn ; Gilbertson, Michael; Lasica, Masa; Anderson, Mary Ann; Renwick, William; Grigg, Andrew P ; Patil, Sush; Opat, Stephen; Friebe, Adam; Cooke, Rachel; De Boer, Jasper; Spencer, Andrew; Ritchie, David; Agarwal, Rishu ; Blombery, Piers |
| 29 | Jul-2022 | Use of a buprenorphine-based pain management protocol is associated with reduced opioid requirements and pain on swallowing in oral mucositis: a retrospective cohort study. | Meyer, Ilonka; Chan, Brandon; Cohen, Emma ; Dube, Esther; Hu, Raymond T C ; Yeomans, Megan; Pontonio, Frances; Heldreich, Charlotte; O'Conghaile, Stiofan ; Holmes, Natasha E ; Maroon, Nada; Weinberg, Laurence ; Tan, Chong O |
| 30 | 28-Jun-2022 | Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder. | Niaz, Aram; Truong, Jia Quyen; Manoleras, Annabel; Fox, Lucy; Blombery, Piers; Vasireddy, Raja S; Pickett, Hilda A; Curtin, Julie A; Barbaro, Pasquale M; Rodgers, Jonathan; Roy, John; Riley, Lisa G; Holien, Jessica K; Cohen, Scott B; Bryan, Tracy |
| 31 | 20-Jun-2022 | Living Long and Well After an Autograft. | Grigg, Andrew P |
| 32 | 14-Jun-2022 | Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study. | Gates, Priscilla ; Krishnasamy, Meinir; Wilson, Carlene J ; Hawkes, Eliza A ; Doré, Vincent ; Perchyonok, Yuliya ; Rowe, Christopher C ; Walker, Adam K; Vardy, Janette L; de Ruiter, Michiel B; Cushion, Tania; Dhillon, Haryana M; Gough, Karla |
| 33 | 6-Jun-2022 | Predictors and Outcomes of Dose Reduction of Methotrexate and Cyclosporin Graft-Versus-Host-Disease Prophylaxis Following Allogeneic Haematopoietic Cell Transplantation. | Ramanan, Radha; Lim, Andrew B M; Tan, Joanne L C; Barmanray, Rahul D; Mason, Kate; Collins, Jenny; Hillman, Matthew; Szer, Jeff; Bajel, Ashish; Ritchie, David |
| 34 | Jun-2022 | Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement. | Enjeti, Anoop K; Agarwal, Rishu ; Blombery, Piers; Chee, Lynette; Chua, Chong Chyn ; Grigg, Andrew P ; Hamad, Nada; Iland, Harry; Lane, Steven; Perkins, Andrew; Singhal, Deepak; Tate, Courtney; Tiong, Ing Soo; Ross, David M |
| 15 | May-2022 | Connection, courage and cancer: A diagnosis of lymphoma in the time of COVID. | Gates, Priscilla |
| 16 | May-2022 | Real-world tolerability of venetoclax-based maintenance therapy with azole antifungal prophylaxis for acute myeloid leukemia in remission. | Nguyen, Phillip C; Donati, Vanessa; Vassili, Catherine; Grigg, Andrew P ; Tiong, Ing S |
| 17 | 7-Apr-2022 | A Decision Shared Is a Decision Halved. | Cliff, Edward R Scheffer |
| 18 | Apr-2022 | The rollercoaster of vaccine-induced immune thrombotic thrombocytopenia. | Cliff, Edward R Scheffer |
| 19 | 28-Mar-2022 | The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma. | Rees, Matthew J ; Panigrahi, Ashish; Harrison, Simon J; Spencer, Andrew; Khong, Tiffany; Gibbs, Simon; Hocking, Jay; Grigg, Andrew P ; Zantomio, Daniela |
| 20 | 23-Mar-2022 | A Centre-Based Comparison of Double vs Single Prevention Strategy on Transfusion Transmitted-Cytomegalovirus in At-Risk Haemopoietic stem cell transplant Patients and a State Survey on CMV-Seronegative Ordering Practices. | Zantomio, Daniela ; Bayly, Emma; Wong, Kimberly; Spencer, Andrew; Ritchie, David; Morgan, Susan; Kelsey, Giles; Dennington, Peta M |
